Arix Bioscience plc: Amplyx Unveils Expanded Pipeline and Reports Phase 2 Data from Lead Programme |
| September 17, 2019 | September 2019 Bond Updates |
|
LONDON, Sept. 17, 2019 /PRNewswire/ -- Arix Bioscience plc (LSE: ARIX) ("Arix"), a global venture capital company focused on investing in and building breakthrough biotech companies, today notes the following updates from its portfolio company Amplyx Pharmaceuticals ("Amplyx"), a biotech... |
| View more at: https://www.prnewswire.com:443/news-releases/arix-bioscience-plc-amplyx-unveils-expanded-pipeline-and-reports-phase-2-data-from-lead-programme-300919410.html |
| Related News |
|